NEW YORK (GenomeWeb News) – Irish diagnostics firm Biotrin announced today a new R&D project to develop automated molecular diagnostics platform technology and assay reagents to detect target DNA and RNA in infectious diseases.
The technology will be based on loop-mediated isothermal amplification, which uses a single temperature incubation.
The project is expected to create 40 new jobs.
Biotrin, owned by Italian firm Diasorin, is based in Dublin, Ireland, and its products include tests for parvovirus B19, HHV-6, HHV-8, and human metapneumovirus.